TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy... Show more
a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
Industry MedicalNursingServices
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PLLAX | 31.10 | 0.29 | +0.94% |
| Principal SmallCap A | |||
| MIOLX | 29.63 | 0.27 | +0.92% |
| Morgan Stanley Inst International Opp L | |||
| TAGRX | 68.85 | 0.59 | +0.86% |
| JHancock Fundamental Large Cap Core A | |||
| BUIEX | 64.66 | 0.46 | +0.72% |
| Buffalo Blue Chip Growth Instl Cl | |||
| MSHPX | 13.51 | 0.03 | +0.22% |
| Morgan Stanley Inst Permanence R6 | |||
A.I.dvisor tells us that TELA and BAX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and BAX's prices will move in lockstep.
| Ticker / NAME | Correlation To TELA | 1D Price Change % | ||
|---|---|---|---|---|
| TELA | 100% | +7.17% | ||
| BAX - TELA | 28% Poorly correlated | -1.57% | ||
| AMIX - TELA | 28% Poorly correlated | -0.34% | ||
| HBIO - TELA | 27% Poorly correlated | -1.47% | ||
| TFX - TELA | 27% Poorly correlated | -0.77% | ||
| AZTA - TELA | 26% Poorly correlated | +2.22% | ||
More | ||||
| Ticker / NAME | Correlation To TELA | 1D Price Change % |
|---|---|---|
| TELA | 100% | +7.17% |
| Medical/Nursing Services industry (141 stocks) | -0% Poorly correlated | +0.38% |
| Health Services industry (242 stocks) | -1% Poorly correlated | +0.38% |
TELA broke above its upper Bollinger Band on September 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 32 similar instances where the stock broke above the upper band. In 32 of the 32 cases the stock fell afterwards. This puts the odds of success at 90%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TELA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Momentum Indicator moved above the 0 level on August 28, 2026. You may want to consider a long position or call options on TELA as a result. In 80 of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.
The Moving Average Convergence Divergence (MACD) for TELA just turned positive on August 31, 2026. Looking at past instances where TELA's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.
TELA moved above its 50-day moving average on September 01, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TELA crossed bullishly above the 50-day moving average on September 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +10.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where TELA advanced for three days, in 175 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. TELA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.305) is normal, around the industry mean (10.682). P/E Ratio (0.000) is within average values for comparable stocks, (67.907). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.653). TELA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.643) is also within normal values, averaging (35.912).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TELA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.